Healthcare news and intelligence for Southern Africa
Daily reporting for the pharmaceutical, medical scheme and hospital sectors, published by Health Matters since 1994.
8 October 2026
Cancer in South Africa is rising, with deaths forecast to nearly double by 2050. Learn what ageing, smoking and urbanisation mean for care.
Latest
8 October 2026
8 October 2026
6 October 2026
6 October 2026
5 October 2026
More news
2 July 2026
Nicholas Crisp’s NHI departure comes as South Africa’s Health Department faces court challenges, senior suspensions and funding pressures.
2 July 2026
The GEMS contribution increase remains at 9.5% after the CMS rejected a further reduction, prompting criticism from public sector unions.
1 July 2026
Ebola treatment trials in the DRC need at least $18m in urgent funding to test experimental drugs and strengthen contact tracing.
1 July 2026
Healthcare access during protests must be protected, SAMA says, as anti-immigration marches raise safety concerns.
1 July 2026
Unsafe cosmetic procedures using unregulated injectables have prompted a national health warning after two patients suffered kidney failure.
29 June 2026
Hospital CEO vacancies are raising concerns about governance, accountability and service delivery across the public health system.
29 June 2026
Shingrix is set to launch in South Africa, promising better shingles protection. Find out what this means for patients and costs.
29 June 2026
Lenacapavir HIV prevention offers twice-yearly PrEP, but trust, access, stigma and continued engagement will determine its impact.
25 June 2026
Global HIV treatment gap leaves 8.8 million people without therapy as funding cuts weaken testing, prevention and community-led services.
25 June 2026
AI alternatives to animal testing can predict toxicity and organ damage while offering more ethical and human-relevant research methods.
25 June 2026
US prescription drug spending is forecast to exceed $560bn in 2026 as demand for GLP-1 obesity and diabetes treatments continues to rise.
23 June 2026
iDexis semaglutide ban stops the pharmacy group from selling compounded weight-loss medicines while SAHPRA and the SAPC investigate.
The archive
Browse every Health Matters article by month.